Study Informs About Risks of Discontinuing Meds in JIA

Many but not all children with juvenile idiopathic arthritis (JIA) can regain remission after stopping and then restarting treatment, according to preliminary data from the ongoing Recapture-JIA study that were presented in a symposium sponsored by the Rheumatology Research Foundation. Dr Sarah Ringold The aim of this study is to evaluate the risks of discontinuing treatment after a period […]

Novartis’s Bid to Repurpose Inflammation Drug Ilaris Takes Another Hit

ZURICH (Reuters) – Novartis’s uphill struggle to re-purpose its inflammation drug Ilaris took another hit when the Swiss drugmaker said on Tuesday that the medicine failed to boost overall survival in lung cancer patients in a late-stage trial. The drug, known generically as canakinumab and long approved to treat juvenile arthritis and rare Mediterranean fever, […]